Loading clinical trials...
Loading clinical trials...
This study will further analyze the use of ceftaroline for CABP and compare its potential to eradicate bacterial pathogens to standard fluoroquinolone therapy. The enhanced spectrum of ceftaroline com...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gary E. Stein, Pharm.D.
Collaborators
NCT06966310 · Community-acquired Pneumonia
NCT07428759 · Pneumonia, Bacterial
NCT06294600 · Community-acquired Pneumonia
NCT07278700 · Acute Respiratory Infections, Febrile Illnesses, and more
NCT07164131 · Community-acquired Pneumonia
Sparrow Hospital
Lansing, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions